India’s pharma industry relies heavily on US market, with $8.07 bn worth of exports in FY 2023-2024. Pharmaceuticals are India’s third largest goods exported to US in dollar terms.
Researchers associated with The Ohio State University found that number of severe adverse events linked to generic drugs made in India was 54% higher than for those made in the US.
India & EFTA (Iceland, Liechtenstein, Norway and Switzerland) are negotiating Trade and Economic Partnership Agreement (TEPA) that is likely to be finalized within next few weeks.
Report by Organisation of Pharmaceutical Producers of India and Ernst & Young says growth could be propelled by expansion in the domestic market, spurred by India's economic growth.
Nearly 80 percent of small and medium drug manufacturing units in India do not follow good manufacturing practices (GMP) requirements, according to government estimates.
The Drugs, Medical Devices and Cosmetics Bill, 2023, is being planned as a substitute for the existing drug law, which was passed during the pre-Independence period.
Chemicals and Fertilisers Minister Mansukh Mandaviya says move will help India become self-reliant in manufacturing key drugs. Most raw materials were so far imported from China.
Once seen as a fading presence on India’s investment & startup picture, the state is slowly moving up the ladder, with policy reforms & infrastructure building.
Agreement signed during 17th Joint Working Group (JWG) on defence cooperation. Defence Secretary Rajesh Kumar Singh met Director General in Israeli Ministry of Defence Amir Baram Tuesday.
This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.
COMMENTS